MCL1 and neuroblastoma: Mcl-1 was suggested as an alternative target of YM155.6 However, YM155 reduced cellular Mcl-1 levels at substantially higher concentrations than survivin, and Mcl-1 depletion did not affect neuroblastoma cell viability.